Which are the causes of Adenomyosis?

The exact cause of Adenomyosis remains unknown, though it is widely believed to result from a breakdown of the barrier between the uterine lining (endometrium) and the muscular uterine wall (myometrium).

Pathophysiology and Mechanisms

Think of the uterus as a house with a protective wall separating the rooms. In Adenomyosis, cells from the lining (the "wallpaper") somehow invade the muscular wall (the "studs"). As these displaced cells continue to behave like normal uterine lining—thickening, breaking down, and bleeding during each menstrual cycle—they cause the muscular wall to thicken, leading to the hallmark symptoms of pain and heavy bleeding.

Genetic and Environmental Factors

While research into the etiology of Adenomyosis is ongoing, there is no single "adenomyosis gene" identified. Instead, researchers suggest a complex interplay between genetic predisposition and environmental triggers. Some studies indicate that women who have undergone uterine surgeries, such as cesarean sections or dilation and curettage (D&C), may have an increased risk, as these procedures could disrupt the protective boundary of the uterine lining.

Distinguishing Causes from Risk Factors

It is important to distinguish between a cause (the underlying mechanism) and a risk factor (a correlation). While parity (number of births) and age are often cited as risk factors for Adenomyosis, they are not the direct cause. Current research is investigating the role of stem cells and the hormonal environment, particularly the influence of estrogen, which may act as a fuel for the misplaced tissue. Furthermore, some researchers are exploring whether Adenomyosis shares an autoimmune component with conditions like endometriosis, given that many patients frequently present with both.

Current Research Directions

Because the condition is often diagnosed only after a hysterectomy, our understanding of the early development of Adenomyosis is still evolving. Recent studies are utilizing advanced imaging and molecular analysis to identify biomarkers that might allow for earlier, non-invasive detection.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• PubMed (National Center for Biotechnology Information): Peer-reviewed research on uterine pathophysiology